Xian International Medical Investment Co Ltd (000516) - Net Assets
Based on the latest financial reports, Xian International Medical Investment Co Ltd (000516) has net assets worth CN¥2.93 Billion CNY (≈ $429.28 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥9.50 Billion ≈ $1.39 Billion USD) and total liabilities (CN¥6.56 Billion ≈ $960.50 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000516 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.93 Billion |
| % of Total Assets | 30.89% |
| Annual Growth Rate | 8.95% |
| 5-Year Change | -43.59% |
| 10-Year Change | -14.05% |
| Growth Volatility | 25.41 |
Xian International Medical Investment Co Ltd - Net Assets Trend (1993–2025)
This chart illustrates how Xian International Medical Investment Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Xian International Medical Investment Co (000516) market capitalisation.
Annual Net Assets for Xian International Medical Investment Co Ltd (1993–2025)
The table below shows the annual net assets of Xian International Medical Investment Co Ltd from 1993 to 2025. Also explore 000516 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.01 Billion ≈ $440.06 Million |
-13.38% |
| 2024-12-31 | CN¥3.47 Billion ≈ $508.06 Million |
-9.02% |
| 2023-12-31 | CN¥3.82 Billion ≈ $558.41 Million |
-10.23% |
| 2022-12-31 | CN¥4.25 Billion ≈ $622.03 Million |
-20.27% |
| 2021-12-31 | CN¥5.33 Billion ≈ $780.16 Million |
+5.92% |
| 2020-12-31 | CN¥5.03 Billion ≈ $736.53 Million |
+0.74% |
| 2019-12-31 | CN¥5.00 Billion ≈ $731.09 Million |
-13.50% |
| 2018-12-31 | CN¥5.78 Billion ≈ $845.24 Million |
+59.10% |
| 2017-12-31 | CN¥3.63 Billion ≈ $531.27 Million |
+3.77% |
| 2016-12-31 | CN¥3.50 Billion ≈ $511.98 Million |
+5.12% |
| 2015-12-31 | CN¥3.33 Billion ≈ $487.04 Million |
+108.37% |
| 2014-12-31 | CN¥1.60 Billion ≈ $233.74 Million |
+24.53% |
| 2013-12-31 | CN¥1.28 Billion ≈ $187.70 Million |
+7.49% |
| 2012-12-31 | CN¥1.19 Billion ≈ $174.63 Million |
+6.72% |
| 2011-12-31 | CN¥1.12 Billion ≈ $163.63 Million |
+4.63% |
| 2010-12-31 | CN¥1.07 Billion ≈ $156.38 Million |
+13.16% |
| 2009-12-31 | CN¥944.36 Million ≈ $138.19 Million |
+34.28% |
| 2008-12-31 | CN¥703.26 Million ≈ $102.91 Million |
+11.63% |
| 2007-12-31 | CN¥629.99 Million ≈ $92.19 Million |
+14.11% |
| 2006-12-31 | CN¥552.09 Million ≈ $80.79 Million |
+9.49% |
| 2005-12-31 | CN¥504.24 Million ≈ $73.79 Million |
+5.69% |
| 2004-12-31 | CN¥477.08 Million ≈ $69.81 Million |
+0.73% |
| 2003-12-31 | CN¥473.61 Million ≈ $69.30 Million |
+11.28% |
| 2002-12-31 | CN¥425.61 Million ≈ $62.28 Million |
+10.49% |
| 2001-12-31 | CN¥385.20 Million ≈ $56.37 Million |
+51.23% |
| 2000-12-31 | CN¥254.71 Million ≈ $37.27 Million |
-10.55% |
| 1999-12-31 | CN¥284.75 Million ≈ $41.67 Million |
+28.55% |
| 1998-12-31 | CN¥221.51 Million ≈ $32.41 Million |
-10.30% |
| 1997-12-31 | CN¥246.96 Million ≈ $36.14 Million |
-10.47% |
| 1996-12-31 | CN¥275.84 Million ≈ $40.36 Million |
-0.19% |
| 1995-12-31 | CN¥276.38 Million ≈ $40.44 Million |
-0.96% |
| 1994-12-31 | CN¥279.06 Million ≈ $40.84 Million |
+44.19% |
| 1993-12-31 | CN¥193.53 Million ≈ $28.32 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Xian International Medical Investment Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2398.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥3.61 Billion | 108.83% |
| Total Equity | CN¥3.32 Billion | 100.00% |
Xian International Medical Investment Co Ltd Competitors by Market Cap
The table below lists competitors of Xian International Medical Investment Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Great Wall Enterprise Co Ltd
TW:1210
|
$1.39 Billion |
|
Fufeng Group Limited
F:FFO1
|
$1.39 Billion |
|
C*Core Technology Co Ltd
SHG:688262
|
$1.39 Billion |
|
Savers Value Village, Inc.
NYSE:SVV
|
$1.39 Billion |
|
ChemoMetec A/S
CO:CHEMM
|
$1.39 Billion |
|
Fangda Special Steel Technology Co Ltd
SHG:600507
|
$1.39 Billion |
|
Amprius Technologies Inc.
NYSE:AMPX
|
$1.39 Billion |
|
Guangdong Xinbao Electrical Appliances Holdings Co Ltd
SHE:002705
|
$1.39 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Xian International Medical Investment Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,674,927,755 to 3,318,161,776, a change of -356,765,979 (-9.7%).
- Net loss of 313,075,396 reduced equity.
- Dividend payments of 149,212,139 reduced retained earnings.
- Other comprehensive income decreased equity by 672,827,914.
- Other factors increased equity by 778,349,470.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-313.08 Million | -9.44% |
| Dividends Paid | CN¥149.21 Million | -4.5% |
| Other Comprehensive Income | CN¥-672.83 Million | -20.28% |
| Other Changes | CN¥778.35 Million | +23.46% |
| Total Change | CN¥- | -9.71% |
Book Value vs Market Value Analysis
This analysis compares Xian International Medical Investment Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.86x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 50.17x to 2.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | CN¥0.08 | CN¥4.24 | x |
| 1994-12-31 | CN¥0.10 | CN¥4.24 | x |
| 1995-12-31 | CN¥0.10 | CN¥4.24 | x |
| 1996-12-31 | CN¥0.11 | CN¥4.24 | x |
| 1997-12-31 | CN¥0.12 | CN¥4.24 | x |
| 1998-12-31 | CN¥0.14 | CN¥4.24 | x |
| 1999-12-31 | CN¥0.16 | CN¥4.24 | x |
| 2000-12-31 | CN¥0.16 | CN¥4.24 | x |
| 2001-12-31 | CN¥0.25 | CN¥4.24 | x |
| 2002-12-31 | CN¥0.26 | CN¥4.24 | x |
| 2003-12-31 | CN¥0.29 | CN¥4.24 | x |
| 2004-12-31 | CN¥0.29 | CN¥4.24 | x |
| 2005-12-31 | CN¥0.30 | CN¥4.24 | x |
| 2006-12-31 | CN¥0.32 | CN¥4.24 | x |
| 2007-12-31 | CN¥0.38 | CN¥4.24 | x |
| 2008-12-31 | CN¥0.85 | CN¥4.24 | x |
| 2009-12-31 | CN¥1.22 | CN¥4.24 | x |
| 2010-12-31 | CN¥0.59 | CN¥4.24 | x |
| 2011-12-31 | CN¥0.63 | CN¥4.24 | x |
| 2012-12-31 | CN¥0.69 | CN¥4.24 | x |
| 2013-12-31 | CN¥0.72 | CN¥4.24 | x |
| 2014-12-31 | CN¥0.89 | CN¥4.24 | x |
| 2015-12-31 | CN¥1.70 | CN¥4.24 | x |
| 2016-12-31 | CN¥1.73 | CN¥4.24 | x |
| 2017-12-31 | CN¥1.86 | CN¥4.24 | x |
| 2018-12-31 | CN¥2.91 | CN¥4.24 | x |
| 2019-12-31 | CN¥2.57 | CN¥4.24 | x |
| 2020-12-31 | CN¥2.59 | CN¥4.24 | x |
| 2021-12-31 | CN¥2.40 | CN¥4.24 | x |
| 2022-12-31 | CN¥1.89 | CN¥4.24 | x |
| 2023-12-31 | CN¥1.70 | CN¥4.24 | x |
| 2024-12-31 | CN¥1.59 | CN¥4.24 | x |
| 2025-12-31 | CN¥1.48 | CN¥4.24 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Xian International Medical Investment Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.44%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.68%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 2.93x
- Recent ROE (-9.44%) is below the historical average (6.38%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 10.38% | 77.34% | 0.08x | 1.69x | CN¥461.24K |
| 1994 | 6.24% | 67.95% | 0.04x | 2.14x | CN¥-5.19 Million |
| 1995 | 2.63% | 10.82% | 0.11x | 2.27x | CN¥-10.45 Million |
| 1996 | 4.98% | 3.09% | 0.63x | 2.57x | CN¥-7.50 Million |
| 1997 | 13.99% | 3.73% | 1.82x | 2.06x | CN¥6.92 Million |
| 1998 | 12.39% | 3.90% | 1.44x | 2.21x | CN¥4.69 Million |
| 1999 | 12.07% | 3.95% | 1.34x | 2.28x | CN¥4.61 Million |
| 2000 | 13.36% | 4.23% | 1.15x | 2.76x | CN¥7.75 Million |
| 2001 | 8.75% | 4.57% | 0.87x | 2.20x | CN¥-4.45 Million |
| 2002 | 9.93% | 3.22% | 1.39x | 2.22x | CN¥-250.58K |
| 2003 | 10.22% | 3.10% | 1.55x | 2.13x | CN¥909.85K |
| 2004 | 7.31% | 1.99% | 1.70x | 2.16x | CN¥-11.03 Million |
| 2005 | 8.92% | 2.35% | 1.40x | 2.71x | CN¥-4.61 Million |
| 2006 | 9.73% | 2.63% | 1.29x | 2.87x | CN¥-1.24 Million |
| 2007 | 14.74% | 4.47% | 1.22x | 2.70x | CN¥25.47 Million |
| 2008 | 9.91% | 2.90% | 1.16x | 2.94x | CN¥-519.03K |
| 2009 | 8.17% | 3.31% | 0.95x | 2.59x | CN¥-17.14 Million |
| 2010 | 14.24% | 6.08% | 0.93x | 2.53x | CN¥45.34 Million |
| 2011 | 11.38% | 3.77% | 1.07x | 2.81x | CN¥15.43 Million |
| 2012 | 9.30% | 3.26% | 0.94x | 3.04x | CN¥-8.31 Million |
| 2013 | 9.50% | 3.41% | 0.99x | 2.82x | CN¥-6.41 Million |
| 2014 | 21.97% | 9.02% | 1.11x | 2.20x | CN¥190.87 Million |
| 2015 | 7.26% | 6.18% | 0.73x | 1.60x | CN¥-91.15 Million |
| 2016 | 5.78% | 5.13% | 0.71x | 1.59x | CN¥-147.15 Million |
| 2017 | 5.37% | 4.79% | 0.70x | 1.61x | CN¥-167.43 Million |
| 2018 | 38.14% | 107.11% | 0.28x | 1.28x | CN¥1.61 Billion |
| 2019 | -8.15% | -40.76% | 0.10x | 2.02x | CN¥-899.49 Million |
| 2020 | 0.91% | 2.82% | 0.13x | 2.42x | CN¥-454.72 Million |
| 2021 | -15.44% | -28.15% | 0.22x | 2.50x | CN¥-1.35 Billion |
| 2022 | -27.68% | -43.40% | 0.20x | 3.12x | CN¥-1.60 Billion |
| 2023 | -9.43% | -7.98% | 0.41x | 2.90x | CN¥-759.16 Million |
| 2024 | -6.92% | -5.28% | 0.45x | 2.89x | CN¥-621.62 Million |
| 2025 | -9.44% | -7.68% | 0.42x | 2.93x | CN¥-644.89 Million |
Industry Comparison
This section compares Xian International Medical Investment Co Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,932,744,528
- Average return on equity (ROE) among peers: 7.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Xian International Medical Investment Co Ltd (000516) | CN¥2.93 Billion | 10.38% | 2.24x | $1.39 Billion |
| Meinian Onehealth Healthcare Holdings Co Ltd (002044) | $3.24 Billion | 8.03% | 0.38x | $2.53 Billion |
| Hengkang Medical Group Co Ltd (002219) | $142.72 Million | 23.68% | 0.66x | $1.04 Billion |
| Aier Eye Hospital Group (300015) | $149.98 Million | 9.73% | 1.22x | $10.97 Billion |
| Liaoning He Eye Hospital Group Co. LTD. (301103) | $861.70 Million | 9.35% | 0.15x | $365.59 Million |
| Chengdu Bright Eye Hospital Co. Ltd. (301239) | $2.32 Billion | 11.56% | 1.08x | $684.62 Million |
| Huaxia Eye Hospital Group Co. Ltd. A (301267) | $6.02 Billion | 7.12% | 0.32x | $1.83 Billion |
| Sanbo Hospital Management Group Ltd. A (301293) | $2.51 Billion | 3.12% | 0.25x | $1.49 Billion |
| Top Choice Medical Investment Co Inc (600763) | $216.22 Million | -14.03% | 0.09x | $2.14 Billion |
About Xian International Medical Investment Co Ltd
Xi'an International Medical Investment Company Limited provides healthcare services in China. It operates hospitals and medical centers. The company also engages in insurance broking, E-commerce, health and asset management, tourism, professional design, technological development, food and beverages, and pharmaceutical production business. The company was formerly known as Xi'an Kaiyuan Investmen… Read more